Potent in vitro and in vivo activity of an Fc-engineered anti-CD19 monoclonal antibody against lymphoma and leukemia.
Horton HM, Bernett MJ, Pong E, Peipp M, Karki S, Chu SY, Richards JO, Vostiar I, Joyce PF, Repp R, Desjarlais JR, Zhukovsky EA.
Cancer Res. 2008 Oct 1;68(19):8049-57.PMID: 18829563 [PubMed - indexed for MEDLINE]Related articlesFree article